|
14.07.2010
Preliminary genetic investigations of fertilised egg cells are permitted under certain conditions. This is at the heart of a landmark decision from the German Supreme Court in Leipzig. Politicians are now pushing for the legal regulation of preimplantation diagnostics and reproductive medicine.
|
|
07.07.2010
What is the best approach to studying the impact of genetically modified plants on the environment? Improving standards for biosafety research was the hot topic at the fourth Round Table on Plant Genetics, which took place on 7 July in Berlin.
|
|
24.05.2010
At a conference in Montpellier in the south of France, prominent molecular biologists and bioinformaticians from around the world discussed how to drive forward genome research towards the establishment of the so-called bioeconomy. The experts want to develop strategy paper together with the OECD.
|
|
22.03.2010
Systems biology research centres funded by the Federal Ministry of Research have been established in four locations across Germany. They have now been evaluated by an international expert commission.
|
|
08.03.2010
After 13 years, the European Commission has finally given the green light for the cultivation of the genetically modified potato Amflora, which is of interest above all for the paper and textile industries, and is not intended for human consumption.
|
|
04.03.2010
Some consider synthetic biology a normal development in biotechnology; others speak of divine creation in the laboratory. Against this background, the German Ethics Council in Berlin has invited participation in the surrounding socio-political discourse.
|
|
05.02.2010
The Genetic Diagnostics Act, which defines strict limits for genetic examinations and is aimed at preventing misuse, has been in force since 1 February.
|
|
15.09.2009
The federal government wants to encourage the use of renewable resources. A plan of action has now been agreed upon, above all aimed at biomass recycling.
|
|
18.08.2009
Advanced therapies, i.e. treatments that make use of human cells, genes and tissues, are generally thought to carry great potential. The EU has now drafted a regulation that is aimed at providing assistance to small companies that might otherwise shrink away from the requirements of centralised approval.
|
|
05.08.2009
Germany has placed an order for the vaccine against Swine flu with the British pharma company GlaxoSmithKline. The production of for the 50 million required doses takes place in Dresden.
|
